117 related articles for article (PubMed ID: 10936581)
1. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
[TBL] [Abstract][Full Text] [Related]
3. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
[TBL] [Abstract][Full Text] [Related]
4. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
[TBL] [Abstract][Full Text] [Related]
6. [Oxidized LDL in patients with coronary heart disease and normal subjects].
Hasegawa A; Toshima S; Nakano A; Nagai R
Nihon Rinsho; 1999 Dec; 57(12):2754-8. PubMed ID: 10638208
[TBL] [Abstract][Full Text] [Related]
7. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL.
Holvoet P; Macy E; Landeloos M; Jones D; Jenny NS; Van de Werf F; Tracy RP
Clin Chem; 2006 Apr; 52(4):760-4. PubMed ID: 16497937
[TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.
Young SG; Smith RS; Hogle DM; Curtiss LK; Witztum JL
Clin Chem; 1986 Aug; 32(8):1484-90. PubMed ID: 3524903
[TBL] [Abstract][Full Text] [Related]
9. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
10. Noncompetitive enzyme-linked immunoassay for apolipoprotein B in serum.
Fievet C; Koffigan M; Ouvry D; Marcovina S; Moschetto Y; Fruchart JC
Clin Chem; 1984 Jan; 30(1):98-100. PubMed ID: 6360423
[TBL] [Abstract][Full Text] [Related]
11. Immunological detection of large oxidized lipoproteins in hypertriglyceridemic serum.
Sakurai T; Wada N; Takahashi Y; Ichikawa A; Ikuta A; Furumaki H; Hui SP; Jin S; Takeda S; Fuda H; Fujikawa M; Shimizu C; Nagasaka H; Furukawa H; Kobayashi S; Chiba H
Ann Clin Biochem; 2013 Sep; 50(Pt 5):465-72. PubMed ID: 23858503
[TBL] [Abstract][Full Text] [Related]
12. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies.
Koren E; Solter D; Lee DM; Reiner Z; McConathy WJ; Dashti N; Alaupovic P
Biochim Biophys Acta; 1986 Mar; 876(1):91-100. PubMed ID: 3081046
[TBL] [Abstract][Full Text] [Related]
14. An immunoenzymatic procedure for human apo B-containing particles quantification using monoclonal antibodies.
Bustos P; Calvo C; Ulloa N; Quiroga A; Sepulveda J
Hybridoma; 1998 Aug; 17(4):395-401. PubMed ID: 9790075
[TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of a particular epitope on plasma apolipoprotein B of patients with coronary artery disease.
Jeng JR; Shieh SM; Chiu HC
Biochim Biophys Acta; 1993 Jun; 1181(3):287-94. PubMed ID: 7686401
[TBL] [Abstract][Full Text] [Related]
17. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human plasma low-density lipoproteins. II. Evaluation for use in radioimmunoassay for apolipoprotein B in patients with coronary artery disease.
Patton JG; Badimon JJ; Mao SJ
Clin Chem; 1983 Nov; 29(11):1898-903. PubMed ID: 6627628
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL.
Kato Y; Tokunaga K; Osawa T
Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
